<DOC>
	<DOC>NCT00408382</DOC>
	<brief_summary>To evaluate the efficacy of intensive lipid-lowering therapy with Lipitor on the changes of characteristics of yellow coronary plaque in subjects with hypercholesteremia accompanying coronary artery disease</brief_summary>
	<brief_title>Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Patients with hypercholesteremia The indication of coronary angiography, coronary angioscopy and intravascular ultrasound are expected Patients who has current administration of Lipitor or history of discontinued administration of Lipitor Acute cardiac infarction</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>Lipitor</keyword>
	<keyword>atorvastatin</keyword>
	<keyword>Hypercholesteremia</keyword>
	<keyword>yellow coronary plaque</keyword>
</DOC>